JHS Svendgaard Laboratories Ltd
Incorporated in 1997, JHS Svendgaard Laboratories Ltd does manufacturing of
oral and dental products for national and international brands[1]
- Market Cap ₹ 83.0 Cr.
- Current Price ₹ 9.50
- High / Low ₹ 16.5 / 8.66
- Stock P/E
- Book Value ₹ 20.3
- Dividend Yield 0.00 %
- ROCE -5.17 %
- ROE -10.8 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.47 times its book value
- Debtor days have improved from 66.0 to 51.8 days.
Cons
- Company has low interest coverage ratio.
- Promoter holding has decreased over last quarter: -0.71%
- The company has delivered a poor sales growth of -7.10% over past five years.
- Promoter holding is low: 33.8%
- Company has a low return on equity of -4.10% over last 3 years.
- Earnings include an other income of Rs.1.29 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35.28 | 55.10 | 99.62 | 104.18 | 138.21 | 119.54 | 132.96 | 96.96 | 79.91 | 84.81 | 70.80 | 92.00 | 94.17 | |
| 39.05 | 58.95 | 93.10 | 92.44 | 121.60 | 111.43 | 123.47 | 93.25 | 79.73 | 93.88 | 71.73 | 96.00 | 95.31 | |
| Operating Profit | -3.77 | -3.85 | 6.52 | 11.74 | 16.61 | 8.11 | 9.49 | 3.71 | 0.18 | -9.07 | -0.93 | -4.00 | -1.14 |
| OPM % | -10.69% | -6.99% | 6.54% | 11.27% | 12.02% | 6.78% | 7.14% | 3.83% | 0.23% | -10.69% | -1.31% | -4.35% | -1.21% |
| -2.67 | -5.76 | -17.30 | 0.40 | 32.03 | 5.09 | 1.09 | 5.50 | 8.14 | -7.31 | 4.31 | 0.02 | 1.29 | |
| Interest | 14.14 | 0.14 | 0.36 | 0.62 | 0.74 | 1.00 | 1.36 | 0.45 | 0.50 | 0.55 | 0.46 | 0.57 | 0.85 |
| Depreciation | 14.70 | 12.35 | 10.49 | 6.36 | 6.81 | 6.98 | 7.43 | 5.56 | 5.90 | 6.02 | 6.35 | 7.95 | 7.66 |
| Profit before tax | -35.28 | -22.10 | -21.63 | 5.16 | 41.09 | 5.22 | 1.79 | 3.20 | 1.92 | -22.95 | -3.43 | -12.50 | -8.36 |
| Tax % | -18.40% | 0.18% | 0.00% | -325.58% | 31.76% | 30.84% | 1.12% | 13.44% | 227.60% | -23.66% | 18.37% | 57.92% | |
| -28.80 | -22.14 | -21.63 | 21.96 | 28.05 | 3.60 | 1.77 | 2.77 | -2.44 | -17.52 | -4.05 | -19.74 | -5.31 | |
| EPS in Rs | -11.95 | -9.19 | -5.75 | 4.98 | 4.61 | 0.59 | 0.29 | 0.43 | -0.38 | -2.70 | -0.52 | -2.31 | -0.62 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | -7% |
| 3 Years: | 5% |
| TTM: | 6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 82% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -8% |
| 5 Years: | -17% |
| 3 Years: | -17% |
| 1 Year: | -27% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | -2% |
| 3 Years: | -4% |
| Last Year: | -11% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 24.10 | 24.10 | 37.64 | 44.12 | 60.90 | 60.90 | 60.90 | 64.40 | 64.90 | 78.40 | 78.40 | 85.60 | 85.60 |
| Reserves | 20.97 | 77.74 | 63.36 | 90.67 | 115.74 | 119.09 | 120.60 | 127.08 | 124.87 | 95.84 | 91.89 | 87.53 | 88.45 |
| 54.00 | 18.72 | 2.47 | 2.19 | 2.46 | 7.02 | 2.56 | 2.47 | 2.17 | 2.58 | 5.13 | 6.46 | 10.59 | |
| 74.16 | 32.93 | 19.25 | 18.60 | 26.33 | 32.68 | 45.57 | 21.01 | 19.26 | 38.65 | 22.04 | 24.61 | 22.66 | |
| Total Liabilities | 173.23 | 153.49 | 122.72 | 155.58 | 205.43 | 219.69 | 229.63 | 214.96 | 211.20 | 215.47 | 197.46 | 204.20 | 207.30 |
| 120.79 | 107.85 | 65.06 | 64.97 | 71.29 | 69.11 | 57.83 | 58.69 | 55.41 | 65.07 | 90.41 | 90.33 | 88.31 | |
| CWIP | 0.03 | 0.03 | 0.68 | 0.67 | 0.42 | 4.74 | 6.98 | 8.85 | 15.83 | 8.57 | 0.82 | 0.00 | 2.95 |
| Investments | 0.01 | 0.01 | 0.01 | 1.04 | 18.20 | 15.36 | 16.52 | 14.21 | 15.39 | 2.98 | 3.46 | 3.65 | 4.89 |
| 52.40 | 45.60 | 56.97 | 88.90 | 115.52 | 130.48 | 148.30 | 133.21 | 124.57 | 138.85 | 102.77 | 110.22 | 111.15 | |
| Total Assets | 173.23 | 153.49 | 122.72 | 155.58 | 205.43 | 219.69 | 229.63 | 214.96 | 211.20 | 215.47 | 197.46 | 204.20 | 207.30 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28.20 | 6.96 | -5.96 | -3.94 | 13.17 | -10.10 | 15.14 | 15.42 | -11.28 | 23.25 | -8.70 | -4.96 | |
| 2.74 | 1.32 | 3.68 | -3.35 | -26.86 | 1.22 | -6.76 | -5.58 | -0.96 | 9.68 | -21.83 | -20.25 | |
| -29.17 | -9.75 | 4.21 | 10.11 | 13.70 | 3.71 | -8.45 | 6.42 | 0.02 | -0.90 | 2.17 | 23.07 | |
| Net Cash Flow | 1.77 | -1.48 | 1.92 | 2.82 | 0.01 | -5.18 | -0.07 | 16.26 | -12.22 | 32.03 | -28.35 | -2.14 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 59.80 | 81.55 | 25.32 | 47.86 | 112.66 | 171.23 | 261.64 | 220.93 | 73.95 | 79.79 | 66.40 | 51.81 |
| Inventory Days | 121.78 | 94.32 | 53.46 | 95.90 | 58.70 | 50.77 | 18.56 | 76.20 | 103.92 | 128.31 | 176.50 | 152.67 |
| Days Payable | 94.92 | 105.71 | 66.63 | 124.98 | 123.29 | 134.26 | 178.94 | 126.45 | 147.17 | 220.72 | 196.58 | 141.41 |
| Cash Conversion Cycle | 86.67 | 70.16 | 12.15 | 18.78 | 48.08 | 87.74 | 101.26 | 170.69 | 30.70 | -12.62 | 46.32 | 63.07 |
| Working Capital Days | -887.46 | -158.25 | 58.26 | 48.49 | 127.74 | 168.03 | 187.66 | 245.82 | 286.62 | 42.09 | 51.40 | 48.44 |
| ROCE % | -10.68% | -13.97% | -2.89% | 4.83% | 9.33% | 3.77% | 7.44% | 1.88% | 1.25% | -2.09% | -1.69% | -5.17% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
12 Feb - Newspaper Publication of Financial Result for Quarter and Nine months ended 31 December, 2025.
-
Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (LODR) Regulation, 2015 For The Quarter Ended December 31, 2025
10 Feb - No deviation for Rs.29.99 crore preferential issue raised 04 Jun 2024; quarter ended 31 Dec 2025.
-
Appointment Of Internal Auditors
10 Feb - Board appointed A.R. & Co. as internal auditor for FY2025-26 to FY2027-28 on Feb 10, 2026.
-
Board Meeting Outcome for Un-Audited Financial Results For The Quarter And Nine Month Ended 31St December, 2025
10 Feb - Board approved Q3/9M unaudited results; conversion of warrants increased paid-up capital to 8,74,05,767 shares; funds utilization disclosed.
-
Un- Audited Financial Result For The Quarter Ended 31St December, 2025
10 Feb - Approved Q3/9M FY26 results; limited review; 16,01,801 warrants converted; paid-up capital now 8,74,05,767 shares.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from nse
Concalls
-
May 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Jun 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022TranscriptAI SummaryPPT
-
Jun 2022Transcript PPT
-
Feb 2022TranscriptAI SummaryPPT
-
Nov 2021TranscriptAI SummaryPPT
-
Aug 2021TranscriptAI SummaryPPT
Business Overview:[1]
JHSSLL manufactures Toothbrushes, Toothpastes, Mouthwash and Denture Tablets. Apart from working on its own brands viz. Dr. Gold, Aquawhite, etc. company also offers Contract Manufacturing Partnership to brands in domestic and international markets